Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test

Specific PHGKB|Cancer|PHGKB

Melanoma Genomics

- Cancer PHGKB -

What's New

Last Posted: Dec 06, 2018

---

• Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test  
  Mirsky Rachel et al. Journal of drugs in dermatology : JDD 2018 Nov 17(11) 1220-1223
• FDA approves ‘precision medicine’ drug for different cancers with same mutation 
  L McGinley, Washington Post, November 26, 2018
• Gene expression profiling in melanoma: past results and future potential.  
  Knackstedt Rebecca W et al. Future oncology (London, England) 2018 Nov
• Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy.  
  Ayers Mark et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov
• Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.  
  Star Phoebe et al. European journal of cancer (Oxford, England : 1990) 2018 9248-53
• A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families.  
  Karimi Masoud et al. Hereditary cancer in clinical practice 2018 1616
• Unscheduled Visits of Patients with Familial Melanoma to a Pigmented Lesion Clinic: Evaluation of Patients' Characteristics and Suspicious Lesions.  
  Nabil Rania et al. Acta dermato-venereologica 2018 Jul 98(7) 667-670
• Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.  
  Latham Alicia et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Oct JCO1800283
• Molecular Testing for Cutaneous Melanoma: An Update and Review.  
  Lee Jonathan J et al. Archives of pathology & laboratory medicine 2018 Oct
• The First Genome Surgeons- Scientists have built tools that can cheaply and easily edit DNA. Now they are preparing to bring them into the clinic to cure disease.  
  A Bleicher, the Medium, October 23, 2018